---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-012538"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2026-04-01T23:59:59+00:00"
generated_at: "2026-05-15T07:57:01.170782+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Femasys appoints John Canning as COO; base $450K, inducement option 150K shares

## Summary
- John Canning appointed COO effective March 30, 2026; annual base salary $450,000 with 40% target bonus.
- Canning previously COO at Terumo Aortic (2017-2026) and Bolton Medical, with 25+ years MedTech experience.
- Granted inducement stock option for 150,000 shares at closing price on grant date; vesting 25% annually over 4 years.
- Appointment aims to strengthen operational capabilities and support commercial growth of FemBloc and FemaSeed.

## SEC filing metadata
- accession: 0001140361-26-012538
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2026-04-01T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036126012538/0001140361-26-012538-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036126012538/ef20069522_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-012538
- JSON: https://secwatch.observer/filing/0001140361-26-012538.json
- Plain text: https://secwatch.observer/filing/0001140361-26-012538.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.